# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-26-030261
Filing Date
2026-07-30
Accepted
2026-07-30 16:36:48
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA 14A | ny20077846x3_defa14a.htm | DEFA14A | 12940
2 |  | logo_ocugen.jpg | GRAPHIC | 40669
3 |  | ny20077846x3_na01.jpg | GRAPHIC | 1243080
4 |  | ny20077846x3_na02.jpg | GRAPHIC | 1295634
| Complete submission text file | 0001140361-26-030261.txt |  | 3562062

Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36751 | Film No.: 261223953
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)